Umthengisi weCaptopril CAS: 62571-86-2

I-Captopril ikwabonakalisiwe ukuba iyathintela ukwenziwa kwe-angiotensin II, i-peptide esebenzayo evuselela i-angiogenesis kwaye yonyusa uxinano lwemithambo yegazi. I-Captopril ibonisa ukuthintela okungekho kukhuphiswano komsebenzi we-tyrosinase monophenolase kunye nokuthintela okukhuphisanayo komsebenzi we-diphenolase. I-Captopril, kunye nezinye izithinteli ze-ACE, iboniswa kunyango lwe-hypertension, ukusilela kwentliziyo okuxineneyo, ukungasebenzi kakuhle kwe-ventricular yasekhohlo emva kwe-myocardial infarction, kunye ne-diabetic nephropathy. Kunyango lwe-diabetic nephropathy enxulumene nesifo seswekile esixhomekeke kwi-insulin, i-captopril inciphisa izinga lokuqhubekeka kokungasebenzi kakuhle kwezintso kwaye ithintela ukonakala komsebenzi wezintso.